Pharma

busy and colorful calendar
Biotech

Sanofi signs 2nd biotech deal of the day

Sanofi is paying Adel $80 million in cash, with the total deal potentially reaching up to $1.04 billion, plus royalties.
Gabrielle Masson Dec 15, 2025 5:50pm
Darts failing to hit bullseye

Aviceda eye disease hopeful fails to top Astellas med in phase 2

Dec 15, 2025 2:14pm
hooded boxer in boxing ring

Immunome's desmoid tumor treatment triumphs in phase 3

Dec 15, 2025 10:42am
Utpal Singh Zealand Pharma

How Zealand CSO aims to create a 'generational biotech leader'

Dec 12, 2025 1:00pm
Cartoon of businessmen standing around a broken target

Arcus halts Gilead-partnered TIGIT trials as it reworks R&D

Dec 12, 2025 10:00am
Close-up macro shot of a glass jar filled with US pennies

Cycle Pharma scoops up beleaguered rare disease biotech

Dec 12, 2025 9:55am